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Tumor Suppressor NM23-H1 Is a Granzyme A-Activated
DNase during CTL-Mediated Apoptosis, and the
Nucleosome Assembly Protein SET Is Its Inhibitor
phosphatase 2A, causes cell cycle arrest and sup-
presses oncogene transformation (Bai et al., 2001; Li et
al., 1996). The NAP activity of SET (also known as PHAPII,
TAF-I, I2PP2A) is abrogated by GzmA degradation (Beres-
ford et al., 2001). SET has been postulated to link the
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Boston, Massachusetts 02115 transcription complex and chromatin (Seo et al., 2001;
Shikama et al., 2000). SET (with its homolog TAF-I) and
pp32 (and its homolog APRIL) are in a150 kDa nuclear
complex that inhibits histone acetylation and DNA de-Summary
methylation and binds HuR, which stabilizes immediate
early gene mRNAs (Brennan et al., 2000; Cervoni et al.,Granzyme A (GzmA) induces a caspase-independent
cell death pathway characterized by single-stranded 2002; Seo et al., 2001, 2002).
The 270–450 kDa SET complex, which contains SET,DNA nicks and other features of apoptosis. A GzmA-
activated DNase (GAAD) is in an ER associated com- pp32, HMG-2, and Ape1, also contains an unidentified
GzmA-activated DNase (GAAD). GzmA-mediated DNAplex containing pp32 and the GzmA substrates SET,
HMG-2, and Ape1. We show that GAAD is NM23-H1, nicking is reconstituted by incubating isolated nuclei
with GzmA-treated SET complex, but not with untreateda nucleoside diphosphate kinase implicated in sup-
pression of tumor metastasis, and its specific inhibitor SET complex (Beresford et al., 2001). Here, we identify
GAAD as the tumor metastasis suppressor NM23-H1(IGAAD) is SET. NM23-H1 binds to SET and is released
from inhibition by GzmA cleavage of SET. After GzmA and show that its specific inhibitor (IGAAD) is SET.
NM23-H1 belongs to a gene family with eight humanloading or CTL attack, SET and NM23-H1 translocate
to the nucleus and SET is degraded, allowing NM23- members (Lacombe et al., 2000). NM23 genes play criti-
cal roles in cellular proliferation, embryonic develop-H1 to nick chromosomal DNA. GzmA-treated cells with
silenced NM23-H1 expression are resistant to GzmA- ment, differentiation, oncogenesis, and tumor metasta-
sis (reviewed in Lascu 2000). The mechanisms for thesemediated DNA damage and cytolysis, while cells over-
expressing NM23-H1 are more sensitive. pleiomorphic effects are not well understood. NM23 pro-
teins are evolutionarily conserved NDP kinases originat-
ing in bacteria, where they catalyze the transfer ofIntroduction
-phosphates between NTPs and NDPs. NM23-H1 and
NM23-H2, the best-studied NM23 proteins, are highlyCytotoxic T lymphocytes (CTL) induce apoptosis of vi-
rus-infected or tumor cells by releasing cytolytic gran- homologous (88% amino acid identity) but have distinct
functions; NM23-H1 was first identified as a tumor me-ules containing a pore-forming protein, perforin, and
granzyme (Gzm) serine proteases (reviewed in Russell tastasis suppressor (Steeg et al., 1988), and NM23-H2
activates c-myc transcription. Both proteins bind andand Ley 2002). Gzms are delivered into the target cell
cytosol by perforin. GzmB triggers apoptosis via cas- nick the nuclease-hypersensitive element of the c-myc
promoter (Postel, 1999). NM23-H1 also recognizes thepase-dependent and -independent mechanisms (Sarin
et al., 1997), which involve direct cleavage of down- 5-SHS silencer and the NHE basal promoter of PDGF-A
as substrates for DNA nicking (Ma et al., 2002).stream caspase substrates. The tryptase GzmA, the
most abundant Gzm in CTL and NK cells, induces an NM23-H1, but not NM23-H2, is in the SET complex
and has DNase activity, which SET inhibits. GzmA cutsalternate caspase-independent pathway with features
of apoptosis, although DNA is damaged by single- SET, removing the inhibition, and triggers NM23-H1 to
move to the nucleus where it nicks chromosomal DNA.stranded nicks, not oligonucleosomal fragmentation
(Beresford et al., 1999; Shresta et al., 1999). Target cells This work provides the description of a DNA damage
mechanism in caspase-independent cell death.resistant to GzmB or the caspases, such as tumors over-
expressing bcl-2, are susceptible to GzmA (Beresford
et al., 1999). Results
Affinity chromatography with the inactive Ser-Ala mu-
tant (S-AGzmA) was used to isolate potential GzmA sub- GzmA Induces DNA Single-Stranded Nicks
strates (Beresford et al., 1997). A 270–420 kDa ER-asso- Loading target cells with GzmA and perforin fails to
ciated complex (SET complex) that binds to immobilized induce oligonucleosomal DNA fragmentation, measured
S-AGzmA contains the tumor suppressor pp32 and by agarose gel electrophoresis, release of detergent
three GzmA substrates: the nucleosome assembly pro- soluble DNA fragments, or TdT labeling (Beresford et
tein (NAP) SET, the DNA bending protein HMG2, and al., 1999; data not shown). However, single-stranded
the base excision repair enzyme Ape1/Ref-1 (Beresford breaks, identified by radiolabeling nicked ends with
et al., 2001; Fan et al., 2002, 2003). Overexpression of Klenow and denaturing agarose gel electrophoresis, are
pp32 (also known as PHAPI, I1PP2A), an inhibitor of protein detected within 4 hr (Figures 1A and 1B). DNA is not
damaged by treatment with GzmA or perforin alone or
with perforin and S-AGzmA. DNA breaks can also be*Correspondence: lieberman@cbr.med.harvard.edu
1These authors contributed equally to this work. visualized in situ by nick translation using Klenow-cata-
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Figure 1. GzmA and Perforin Induce Single-Stranded DNA Nicks
(A and B) Loading GzmA, but not S-AGzmA, into K562 cells with perforin (P) induces DNA damage within 4 hr. Klenow-radiolabeled nicked
DNA in isolated treated nuclei was analyzed by scintillation counting (A) and denaturing agarose gel electrophoresis (B).
(C) DNA nicks after GzmA treatment of isolated nuclei, observed by in situ fluorescence, requires active enzyme and cytosol. Isolated K562
nuclei were treated with GzmA or S-AGzmA with or without cytosol. Nicks were labeled with Alexa 568-dUTP (red), and SYTOX green was
used for counterstaining. DNase I is a positive control.
(D) ICAD/DFF45, but not CAD, is degraded in cells perforin-loaded with GzmB (B), but not with GzmA (A) or the S-A mutants (S-AB, S-AA).
Lysates were analyzed by immunoblot 4 hr after loading.
(E) ICAD is not cleaved when K562 cell lysates are incubated directly with GzmA for 2 hr at 37C. S-AGzmA was at 1 M. SET is probed as
positive control.
lyzed incorporation of fluorophore-labeled dUTP (Figure The SET Complex Contains a GzmA-Activated
DNase and Its Inhibitor1C). Labeling isolated K562 nuclei by GzmA requires a
small amount of cytosol plus active enzyme and occurs We previously postulated that GAAD is in the SET com-
plex since the SET complex, isolated by S-AGzmA affin-throughout the condensed chromatin and along the nu-
clear envelope (Figure 1C). ity purification and gel filtration (Figure 2A), is all that is
required for GzmA to activate DNA damage in isolatedThe caspase-activated DNase (DFF40/CAD) makes
blunt double-stranded breaks after its inhibitor DFF45/ nuclei (Figures 2B and 2C) (Beresford et al., 2001). In
vitro plasmid DNA cleavage by the SET complex is Mg2ICAD is cleaved by caspases (Enari et al., 1998; Liu
et al., 1997). GzmB cuts ICAD directly or indirectly by dependent and sequence independent but requires pro-
longed incubation (48 hr at 37C), suggesting that theactivating caspases (Sharif-Askari et al., 2001; Thomas
et al., 2000), but GzmA loading with perforin (Figure 1D) SET complex contains not only GAAD, but possibly an
inhibitor (IGAAD). GzmA inactivates the inhibitor sinceor treatment of cell lysates (Figure 1E) does not lead to
ICAD cleavage. plasmid DNase activity is detected within 2 hr if the SET
NM23-H1 Is a Granzyme A-Activated DNase
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Figure 2. The SET Complex Contains GAAD and Its Inhibitor
(A) Purification scheme of GAAD. The 270–450 kDa SET complex elutes from cell lysates applied sequentially to immobilized S-AGzmA and
S400 columns. The pooled S400 fractions were further separated on a Q column.
(B and C) GzmA activates nuclease activity in the SET complex (SC). Isolated Jurkat nuclei were treated with GzmA or S-AGzmA and SC and
then radiolabeled with Klenow, detected by counting (B) or alkaline agarose gel electrophoresis (C).
(D) GzmA-treated SET complex induces pcDNA3 DNA degradation. S-AGzmA concentration, 0.3 M. DNase I is the positive control. M, 1 kb
DNA markers.
(E) The Q column separates a DNase in the flowthough (QFT) from an inhibitor in the eluate (QE). Plasmid DNA was incubated with QFT and/
or QE. The QFT DNase was inhibited completely by the QE.
(F) The QE inhibitor coelutes from the Q column with SET. Plasmid DNA, coincubated with QFT and the indicated QE fractions, was analyzed
by agarose gel electrophoresis (above). QE fractions were probed for SET (below).
(G) The SET complex reassembles topoisomerase-relaxed (R) plasmid DNA around histones into its supercoiled (S) form.
Cell
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Figure 3. ER-Associated GAAD Is NM23-H1
(A) The SET complex QFT DNase, visualized by SDS-DNA-PAGE, migrates with an apparent mass of 17 kDa. No DNase was in mock- or
GzmA-treated rSET or in GzmA or rpp32 (data not shown). DNase I is a positive control.
(B) A 17 kDa band in the QFT was identified as NM23-H1 by mass spectrometry. The SET complex from the S400 column and pooled QE
and QFT fractions were analyzed by Coomassie staining (above) and by immunoblot (below). SET and pp32 are in the QE. NM23-H1, Ape1,
and HMG2 are in the QFT. NM23-H2 is not in the SET complex, but is detectable in cytosol.
(C) NM23-H1 coelutes from the S-AGzmA column with SET and Ape1, HMG2, and pp32 (data not shown). Immunoblot was probed with NM23-
H1 mAb and SET polyclonal antiserum.
(D) rNM23-H1 has DNase activity. The rNM23-H1 fractions from the final DEAE purification step were analyzed by Coomassie staining and
by EtBr-stained agarose and SDS-DNA-PAGE gels for nicking of plasmid and eukaryotic DNA, respectively.
(E) rNM23-H1 cuts plasmid DNA at nanomolar concentrations. Control recombinant GST, pp32, or SET proteins have no DNase activity.
(F) rNM23-H1 can replace GzmA-treated cytosol or SET complex to nick DNA in isolated nuclei.
NM23-H1 Is a Granzyme A-Activated DNase
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Figure 4. SET Binds and Inhibits GAAD
(A–C) rSET binds directly to rNM23-H1. rSET and rNM23-H1 were coprecipitated with NM23-H1 mAb (left) or SET antiserum (right). Native
SET and NM23-H1 in the SET complex (B) or K562 cell lysates (C) also coprecipitate with antibody to NM23-H1 (left) or SET (right). Pretreating
lysates with GzmA blocks coprecipitation.
(D) Immunodepletion of NM23-H1 or SET in the SET complex, but not their homologs NM23-H2 or TAF-I, abolishes GAAD activity. SET
complex was immunodepleted with preimmune serum, protein A-purified IgG, or indicated antibodies and Protein A Sepharose (Pharmacia).
Supernatants were then treated with 0.3 M GzmA and added to isolated nuclei. DNA nicking was measured as in Figure 1A. Control lanes
show no nicking in nuclei treated only with SET complex or GzmA.
(E) DNA nicking by GzmA-activated SET complex rescued after immunodepletion by adding back rNM23-H1, but not rNM23-H1 plus SET.
Experiment was performed as in (D), but indicated proteins were added to supernatants just prior to adding nuclei.
(F) rSET, but not rpp32, inhibits rNM23-H1 nuclease activity.
(G) GzmA, but not S-AGzmA, releases the IGAAD activity of rSET and allows rNM23-H1 to degrade plasmid DNA. M, 1 kb DNA markers.
complex is pretreated with GzmA, but not with S-AGzmA Moreover, mixing the QE with the QFT abrogates DNA
cleavage (Figure 2E). The inhibitory QE fractions coin-(Figure 2D). To identify GAAD, the SET complex was
separated over an anion exchange Q column. SET and cide with the fractions that contain SET and pp32 (Figure
2F; data not shown). Inhibition is specific since the QEpp32 bind to the Q column, while Ape1 and HMG-2 are
in the flowthrough (QFT) (Figure 3B). CAD and ICAD are does not inhibit DNase I (data not shown). Therefore,
GAAD is in the QFT, and IGAAD is in the QE. Moreover,not in the SET complex (data not shown). The Q column
eluate (QE) does not cut plasmid DNA, but the QFT does. the intact SET complex, like SET itself, has NAP activity,
(G–I) In (G), GzmA does not cut rNM23-H1. rNM23-H1, rSET, or rpp32, treated with GzmA or 1M S-AGzmA, were analyzed by immunoblot.
GzmA also does not degrade native NM23-H1 in K562 cell lysates (H) or when GzmA is loaded with perforin (P) into K562 cells (I). SET, but
not pp32 or TAF-I, is cleaved under these conditions.
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Figure 5. NM23-H1 Colocalizes with SET and Rapidly Translocates to the Nucleus after CTL Attack
(A) NM23-H1 and SET colocalize with each other and with the ER-resident protein calreticulin in HeLa cells. TRITC red fluorescence is shown
at left, FITC staining green in the middle, and the merged image at right.
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which is destroyed by GzmA (Beresford et al., 2001) loaded with GzmA and perforin (Figure 3I). Native NM23-
H1 is unchanged 4 hr after GzmA treatment, while SET(Figure 2G; data not shown).
(but not its homolog TAF-I) is cleaved within 20 min.
SET Complex GAAD Is NM23-H1
SDS-DNA-PAGE identifies nucleases separated on gels SET Binds to GAAD and Is Its Inhibitor
GzmA does not activate DNA damage by cutting NM23-impregnated with calf thymus DNA by EtBr-negative
bands that emerge after renaturation. A 17 kDa band is H1. However, GAAD might be activated by cleaving its
inhibitor IGAAD, just as CAD is activated by ICAD cleav-in the QFT, but not in the QE, GzmA-treated QE, or
recombinant QE proteins (Figure 3A; data not shown). age. Since IGAAD is in the QE of the SET complex frac-
tionation, we determined which SET complex proteinsThis 17 kDa QFT protein was identified as NM23-H1 at
the Harvard Microchemistry Facility by microcapillary bind NM23-H1. rNM23-H1 coprecipitates with rSET, but
not with rpp32, rHMG-2, or rApe1 (Figure 4A; data notreverse phase HPLC nanoelectrospray tandem mass
spectroscopy by sequence identity of 12 tryptic frag- shown). Native NM23-H1 and SET in the SET complex
(Figure 4B) or cell lysates (Figure 4C) also coprecipitate.ments and confirmed by immunoblot probed with NM23-
H1 mAb (Figure 3B). The association of NM23-H1 is GzmA cleavage dissociates SET and its fragments from
NM23-H1, since coprecipitation is not detected afterspecific, since NM23-H2 is not in the complex. NM23-
H1, but not NM23-H2, also coelutes with SET and other GzmA treatment even with polyclonal SET antiserum
(Figure 4C; data not shown).SET complex proteins from the S-AGzmA column (Fig-
ure 3C; data not shown). As expected if SET and NM23-H1 bind, immunodeple-
tion of NM23-H1 or SET, but not control antibody orTo determine whether recombinant NM23-H1 (rNM23-
H1) is a DNase, rNM23-H1 protein was purified from Protein A, abolishes DNA nicking by GzmA and SET
complex in isolated nuclei (Figure 4D). Depletion withbacteria using ammonium sulfate precipitation, hy-
droxyapatite, ATP agarose, and DEAE chromatography. antibodies to TAF-I or NM23-H2 does not interfere with
DNA nicking, showing the specificity of SET and NM23-Coomassie staining of PAGE gels of the final DEAE col-
umn elution reveals a solitary rNM23-H1 band (Figure H1 in this process. DNA nicking after immunodepletion
is rescued by adding back rNM23-H1 (Figure 4E). How-3D). DNase activity against plasmid and eukaryotic DNA,
visualized on agarose and SDS-DNA-PAGE gels, respec- ever, adding both rNM23-H1 and SET in equimolar
amounts does not restore nicking.tively, coincides with fractions containing rNM23-H1.
rNM23-H1 cleavage of plasmid DNA is dose dependent Because SET binds NM23-H1 and is a GzmA sub-
strate, we tested whether rSET inhibits the rNM23-H1and readily detected at low nanomolar concentrations
(Figure 3E). Control recombinant proteins (rGST, rSET, or nuclease. rSET, but not rpp32, blocks plasmid degrada-
tion by NM23-H1 (Figure 4F). Inhibition is specific sincerpp32) have no nuclease activity at 500 nM. The DNase
activity of NM23-H1 is Mg2 dependent (data not rSET does not inhibit DNase I (data not shown). rpp32
does not suppress the DNase activity of NM23-H1, evenshown), like GAAD activity in the SET complex. rNM23-
H1 can replace GzmA-treated cytosol or SET complex to in 10-fold molar excess. Therefore, SET is IGAAD. To
determine whether GzmA releases SET inhibition,reconstitute DNA nicking activity in isolated Jurkat nuclei,
but does not require GzmA to activate it (Figure 3F). rNM23-H1 was incubated with rSET or GzmA-pretreated
rSET prior to adding plasmid DNA. GzmA, but not
S-AGzmA, treatment of rSET abrogates NM23-H1 inhibi-NM23-H1 Is Not a GzmA Substrate
tion (Figure 4G).Since rNM23-H1 is a DNase, NM23-H1 need not be a
GzmA substrate. To determine whether NM23-H1 and
GzmA interact directly, we tried to coprecipitate the NM23-H1 Colocalizes with SET and Moves Rapidly
to the Nucleus after CTL Attackrecombinant proteins. rNM23-H1 does not coprecipitate
with S-AGzmA, although recombinant GzmA substrates We previously showed that SET and pp32 are predomi-
nantly cytoplasmic and associate with the ER (BeresfordSET, HMG-2, and Ape1 do (data not shown). However,
native NM23-H1 in the SET complex or in cell lysates et al., 2001). In HeLa cells costained for NM23-H1 and
SET, NM23-H1 colocalizes with SET and the ER-residentcoprecipitates with S-AGzmA, suggesting an indirect
interaction via other SET complex proteins (data not protein calreticulin (Figure 5A). Most NM23-H1 and SET
are also in the cytosol, not the nucleus, when fraction-shown). Furthermore, a molar excess of GzmA does
not cut rNM23-H1 (Figure 3G). As expected, GzmA cuts ated HeLa or K562 cells are analyzed by immunoblot
(Figure 5C; data not shown).rSET, but not rpp32. These results were verified by prob-
ing for NM23-H1, SET, and pp32 in K562 cell lysates To look at changes in NM23-H1 and SET during CTL
attack, lymphokine-activated killer (LAK) cells were cen-incubated with Gzms (Figure 3H) or in intact K562 cells
(B) NM23-H1 and SET translocate to the nucleus of target cells immediately after LAK attack. HeLa cells were pretreated with conA (middle
and right) or medium (left) in the presence of EGTA (to prevent cytotoxic granule release) before adding LAK cells (right) or medium (left,
middle). Cells were fixed 5 min after adding CaCl2 to initiate LAK cell granule exocytosis. Calreticulin is stained green; SET (top) and NM23-
H1 (bottom) are red. All images are merged. The small cells in the right figures are LAK cells. SET also translocates to the nucleus in LAK
cells.
(C) Nuclear translocation of NM23-H1 and SET after LAK attack of HeLa cells (as in [B]) assessed by immunoblot of cytoplasmic (C) and
nuclear (N) NP40 cell lysates. NM23-H1 and SET are mostly in the cytosol in mock-treated cells and translocate within 5 min of LAK attack.
NM23-H1 is not degraded. Cleaved SET is only detected in the nucleus. Calreticulin is a loading and fractionation control.
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trifuged onto concanavalin A (ConA)-treated HeLa tar- The siRNAs chosen to silence NM23-H1 do not alter
NM23-H2 expression (Figure 6A). To verify that thegets in medium containing EGTA to prevent granule
exocytosis. After adding Ca2 to initiate cytolysis, slides NM23-H1 homolog NM23-H2 is not involved in GzmA-
mediated DNA damage, we also tested whether DNAwere fixed and stained for NM23-H1, SET, and calre-
ticulin (Figure 5B). Within 5 min, NM23-H1 and SET trans- nicking is reduced in NM23-H2-silenced cells (Figure
6C). NM23-H2 was not detected by immunoblot in cellslocate from the cytoplasm to the nucleus of target cells
and stain the nucleoplasm diffusely, avoiding the nucle- transfected 3 days earlier with siRNA duplex #1, while
siRNA#2 inhibited NM23-H2 expression by 60%.olus. Adding just calcium to ConA-treated or untreated
HeLa cells does not induce significant translocation. Of NM23-H2-silenced cells have comparable GzmA-
induced nicking as control cells (mean 105 cpm in NM23-note, SET also moves to the nucleus of LAK cells within
5 min of adding Ca2. The signal for NM23-H1 in LAK H2 versus GFP-silenced cells: siRNA#1, 2.7 0.1 versus
3.0  0.1, p 	 0.05; siRNA#2, 3.1  0.2 versus 2.9 cells is harder to delineate but does not appear to
change within the first 5 min. 0.2, p 	 0.05).
Changes in NM23-H1 and SET were also analyzed by
immunoblot of cytosolic and nuclear fractions of target- Overexpressing NM23-H1 Enhances
LAK cell mixtures obtained in the hour after LAK attack GzmA-Induced DNA Breaks
(Figure 5C). Most NM23-H1 and SET is in HeLa cytosol To validate further the role of NM23-H1 in GzmA-induced
before attack. LAK cell NM23-H1 or SET is not detected DNA damage and cell death, NM23-H1 was overex-
when equal numbers of LAK and HeLa cells are loaded, pressed by transfection with pCMV-NM23-H1. Cells
either because of lower expression or because LAK cells transfected with NM23-H1, but not control, plasmid have
are much smaller. Therefore, blots of the cell mixtures a dose-dependent increase in NM23-H1 expression
detect NM23-H1 and SET in the targets. Within 5 min, (Figure 6D), which parallels increased GzmA-initiated
the SET cleavage fragment is detected (only in the nu- nicking (Figure 6E). Cells overexpressing NM23-H1 are
cleus) and increases over 20 min. Cytosolic full-length also more susceptible than GFP-transfected cells to
SET declines with time, but the cleavage fragment is GzmA and perforin-mediated cytolysis (specific cyto-
not seen in the cytosol. Therefore, either the cleaved toxicity, 91%  7% versus 65%  5%, p 
 0.001).
fragment moves rapidly to the nucleus or most SET However, when NM23-H2 is overexpressed, GzmA-
cleavage occurs after translocation. NM23-H1 translo- induced DNA nicking is unaltered (Figure 6F).
cation to the target cell nucleus occurs with similar kinet-
ics, but NM23-H1 is not degraded. Calreticulin, a control Silencing SET Enhances and Overexpressing SET
for fractionation and loading, is unchanged. Similar re- Diminishes GzmA-Induced DNA Nicks
sults were found after loading GzmA and perforin into To verify the role of SET as IGAAD, SET was silenced
K562 cells (data not shown). using siRNAs designed to target SET, but not its close
homolog TAF-I. Transfection of siRNA#1 inhibits SET
expression by 60%, while siRNA#2 blocks expressionSilencing NM23-H1, but Not NM23-H2, Decreases
almost completely; neither interferes with TAF-I (FigureGzmA-Induced DNA Nicks
6G). Cells with silenced SET expression are more sensi-As further evidence that NM23-H1 is a GAAD, NM23-H1
tive to GzmA-induced DNA breaks compared to cellsexpression was silenced using RNA interference (RNAi)
treated with GFP-siRNA, and DNA damage increases(Elbashir et al., 2001). Two siRNA duplexes targeting
with more complete silencing (mean 105 cpm in SET-NM23-H1 were transfected into K562 cells. Three days
silenced versus GFP-silenced cells: siRNA#1, 3.5  0.2later, NM23-H1 expression is not detected in cells trans-
versus 2.2  0.2, p 
 0.001; siRNA#2, 4.8  0.3 versusfected with either siRNA duplex, while cells transfected
2.5  0.2, p 
 0.001) (Figure 6G).with control siRNA targeting GFP have unchanged
Overexpressing SET in K562 cells by transfectingNM23-H1 expression (Figure 6A). Cells with silenced
pcDNA3.1-SET also leads to a dose-dependent increaseNM23-H1 expression have many fewer DNA breaks
in SET expression and a corresponding decrease in(measured by Klenow labeling) after GzmA treatment of
GzmA-induced DNA breaks (Figure 6H). The mean 105cell lysates compared to cells treated with GFP-siRNA
cpm in SET-overexpressing versus GFP-overexpressing(mean 105 cpm in NM23-H1 versus GFP-silenced cells:
cells was: 3.1  0.2 versus 3.4  0.05, p 
 0.01 (0.2 gsiRNA#1, 1.4 0.1 versus 4.2 0.1, p
 0.001; siRNA#2,
DNA); 1.8  0.2 versus 3.7  0.2, p 
 0.001 (0.4 g);1.6 0.1 versus 4.5 0.2, p
 0.001) (Figure 6B). NM23-
and 1.3 0.2 versus 3.6 0.2, p
 0.001 (0.8 g). TheseH1 silencing also interferes with GzmA-mediated cytoly-
experiments with altered SET expression confirm thesis. When GzmA is loaded with perforin into 51Cr-labeled
inhibitory role of SET in DNA damage by GzmA.HeLa cells 3 days after transfection, HeLa cells with
silenced NM23-H1 are nearly twice as resistant to
GzmA-induced cytolysis as GFP-silenced cells (specific Discussion
cytotoxicity, 48%  4% versus 79%  6%, p 
 0.001).
There are no substantial differences in background lysis GzmA was thought to activate cell death slowly because
oligonucleosomal DNA fragments are not released from(
10%) by GzmA or perforin alone or by perforin and
S-AGzmA due to siRNAs. Because NM23-H1 silencing target cells until 16 hr after GzmA treatment. However,
GzmA activates a type of DNA damage (single-strandeddoes not completely abrogate DNA nicking, we cannot
be certain that NM23-H1 is the only GAAD. However, nicks), which leads to larger DNA fragments, not de-
tected in conventional apoptotic assays using nondena-RNAi does not usually completely abolish targeted gene
expression. turing agarose gels or TdT labeling. Nonetheless, DNA
NM23-H1 Is a Granzyme A-Activated DNase
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Figure 6. Silencing NM23-H1 Expression Decreases and Overexpressing NM23-H1 Enhances GzmA-Induced DNA Damage
(A) NM23-H1 expression is silenced in HeLa cells after treatment with siRNA duplexes against NM23-H1. NM23-H2 and -actin expression
are unchanged.
(B) Silencing NM23-H1 significantly decreases GzmA-induced DNA damage, measured as in Figure 1A, and cytolysis of perforin and GzmA-
loaded cells.
(C) Silencing NM23-H2 does not affect DNA nicking activated by GzmA.
(D and E) HeLa cells transfected with pCMV-NM23-H1, but not control plasmid pCMV-GFP, overexpress NM23-H1 in a plasmid dose-dependent
manner. Blots of cell lysates were probed for NM23-H1 and -actin. Numbers represent the ratio of NM23-H1 to -actin signal by densitometry,
normalized to control cells. NM23-H1 overexpression enhances GzmA-mediated DNA nicks in parallel with NM23-H1 expression (E).
(F) Overexpressing homologous NM23-H2 has no effect on DNA nicking.
(G and H) Silencing SET enhances (G), while overexpressing SET diminishes (H), GzmA-induced DNA damage.
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damage occurs within 4 hr and can be detected in situ
and in vitro by labeling single-stranded nicked DNA with
Klenow. Moreover, GzmA-induced cell death occurs
within minutes, as rapidly as with GzmB (data not
shown). Although these results are not completely physi-
ological since they are obtained using recombinant
granzymes and purified perforin, it is likely that the same
kinetics occur after CTL granule release. However, the
kinetics of granzyme A-mediated cell death in a more
physiologically relevant setting require further study,
which should be possible with CTLs from mice geneti-
cally deficient in granzyme B.
Granzyme A-induced cell death is marked by rapid
induction of other apoptotic features, including loss of
membrane integrity with blebbing, loss of mitochondrial
potential, and production of reactive oxidative species
(D.M. and J.L., unpublished), chromatin condensation,
and nuclear fragmentation (Beresford et al., 1999; Fan
et al., 2003). However, the biochemical hallmarks of the
caspase pathway, such as mitochondrial cytochrome c
release, oligonucleosomal DNA fragmentation, caspase
activation, and inhibition by bcl-2 overexpression, are
absent (Beresford et al., 1999). Moreover, the known
GzmA intracellular targets (SET, HMG-2, Ape1, lamins
A–C, and histones) are (with the exception of lamin B)
all unique to this pathway (Beresford et al., 1997; Fan et
al., 2002, 2003; Zhang et al., 2001a, 2001b). This pathway
Figure 7. Model for DNA Damage during CTL-Mediated Apoptosistherefore provides an immune mechanism to eliminate
CTL granules containing perforin and granzymes are released intotumors and viruses that can evade caspase-mediated
the synapse formed with the target cell. Gzms enter the target cellapoptosis.
cytoplasm either via perforin-induced perturbation of the plasmaGzmA targets the SET complex, which contains pp32
membrane or through endocytosis. GzmA cleaves IGAAD (SET),and three GzmA substrates, SET, HMG-2, and Ape1
which then no longer binds and inhibits GAAD (NM23-H1). Our ex-
(Beresford et al., 1997; Fan et al., 2002, 2003). We now periments do not define whether SET is cleaved in the cytoplasm
show that the SET complex holds the key to the unique or nucleus or both. Uninhibited GAAD in the nucleus makes single-
DNA damage induced by GzmA. A new SET complex stranded DNA nicks. GzmB directly or indirectly via caspases de-
stroys the CAD inhibitor ICAD. Cleaved ICAD no longer binds CAD,component is NM23-H1, an evolutionarily conserved
which then moves to the nucleus to cause double-stranded breaks.NDP kinase previously known to nick DNA (Ma et al.,
2002). NM23-H1 is a GAAD, and SET is its inhibitor.
GzmA activates the DNase by cleaving SET, disrupting
Moreover, Ape1 translocates rapidly into the nucleus inits binding to NM23-H1 and releasing it from inhibition
response to ROS generated during GzmA-induced cell(Figure 7). This mechanism recalls the activation of CAD
death (Tell et al., 2000). Therefore, we suspect that theby caspase or GzmB cleavage of ICAD. In both path-
SET complex translocates as a complex in response toways, the DNase is sequestered in the cytosol bound to
GzmA loading, although this remains unproven. Of note,its inhibitor, until the inhibitor is proteolytically cleaved.
SET (but maybe not NM23-H1) also moves to the nucleusDuring cell death, the uninhibited DNase translocates
of LAK cells activated to lyse target cells (Figure 5B).to the nucleus.
This result suggests that SET may play a role in nuclearThe signals that regulate SET complex nuclear trans-
events in cellular activation. In fact, SET has been postu-location are unknown. However, the functions of these
lated to link transcriptional activation with histones (Seoproteins suggest they should spend time in the nucleus.
et al., 2001; Shikama et al., 2000).In this study, SET and NM23-H1 in target cells move to
NM23-H1 was identified on the basis of low expres-the nucleus within minutes of GzmA loading. Although
sion in metastatic cells (Steeg et al., 1988). Since then,the SET fragment is only seen in the nucleus, further
low expression or mutation of NM23-H1 and NM23-H2experiments are required to determine whether SET is
have been implicated in cancer prognosis or metastasiscleaved only in the nucleus or whether SET fragments
in a variety of tumors and malignant transformation.produced in the cytosol are not detected there because
However, how NM23 proteins enhance malignancy isthey are unstable or rapidly translocate.
not completely understood. Most NM23 family membersGzmA translocates to the nucleus during CTL attack
are NDP kinases (reviewed in Lascu, 2000). NDP kinases(Fan et al., 2003; Jans et al., 1999), although how GzmA
were originally thought of as essential housekeepinggets in is not known. Possibly, one of the SET complex
enzymes required for maintaining NTP pools. However,proteins is involved in its transport. pp32, which has
NDP kinase is not essential for viability in E. coli and innuclear import and export sequences (Brennan et al.,
yeast. Deletion of the ndk gene in E. coli produces a2000), also translocates with SET (P.J.B. and J.L., un-
mutator phenotype, suggesting DNA repair defects (Lupublished data) and Ape1 also concentrates in the nu-
cleus within minutes of GzmA loading (Fan et al., 2003). et al., 1995; Postel et al., 2000), and a deficient strain in S.
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pombe has developmental abnormalities (Izumiya and factors involved in the immediate early gene response,
Yamamoto, 1995). The close homolog NM23-H2 was including fos, jun, NF-B, and p53 (Gaiddon et al., 1999;
first identified as a DNA binding protein that enhances Xanthoudakis et al., 1992). The simplest model tying all
c-myc transcription (Postel et al., 1993). However, DNA these known functions together is that the SET complex
binding and NDP kinase activity are controlled by inde- is involved in repair and transcriptional activation in re-
pendent functional domains of NM23-H2 (Postel et al., sponse to oxidative stress. The SET complex appears
1996). NM23-H2 preferentially binds to paranemic DNA to move into the nucleus rapidly in response to ROS.
structures and nicks the c-myc NHE promoter through Oxidative stress might also accompany normal cellular
a covalent protein DNA complex involving a DNA glyco- activation because of enhanced cellular metabolism.
sylase/lyase reaction (Postel et al., 2000). Perhaps DNA This might explain SET translocation even in LAK cells
nicking involves NM23 transfer of a phosphoryl group to not threatened with death. Moreover, coupling DNA re-
DNA. Mutational and structural analysis implicate seven pair to transcription, recently described in other path-
critical NM23-H2 residues for covalent DNA binding, ways (Monteiro 2000), is an efficient way to guarantee
DNA cleavage, and NDP kinase activity (Postel et al., that DNA is repaired before the activated cell repli-
2002). These seven residues are conserved between cates DNA.
NM23-H1 and NM23-H2, indicating that NM23-H1 may Chromatin degradation in apoptosis may involve more
have similar activities as NM23-H2. In fact, NM23-H1 than one endonuclease. During apoptosis, genomic
represses PDGF-A transcription and nicks the PDFG-A DNA is initially cut to 50–300 kb fragments followed by
5-SHS silencer and NHE basal promoter (Ma et al., ultimate degradation to 180–200 bp oligonucleosomal
2002). Although both NM23-H1 and NM23-H2 nick DNA, fragments (Kokileva, 1994; Lagarkova et al., 1995). The
their cleavage recognition sites and mechanisms appear last step involves the caspase-activated DNase (CAD)
to be different. In this study, NM23-H1, but not NM23- and, possibly, mitochondrial endoG (Enari et al., 1998;
H2, is in the SET complex and plays a role in GzmA- Li et al., 2001; Liu et al., 1997). CAD shows weaker
mediated death. nuclease activity on naked DNA than chromosomal
How does the inclusion of NM23-H1 in the SET com- DNA, suggesting that CAD may require other factors for
plex and its role as GAAD help us understand the normal optimal activity (Toh et al., 1998). In fact, CAD activity
function of NM23-H1 and the SET complex? First, this is enhanced by the SET complex protein HMG-2 and a
study confirms that NM23-H1 has DNA nicking activity. recently described helicase (Kovacsovics et al., 2002).
Its coassociation with Ape1, the rate-limiting enzyme in Until now, no other DNase responsible for DNA nicking
BER, suggests that NM23-H1 may act as a DNA glycosy- in apoptosis has been identified. However, IGAAD is not
lase/lyase in concert with Ape1 in repairing oxidative cleaved by GzmB or during caspase-mediated apopto-
DNA damage, since glycosylases are the first step in sis. Moreover, CAD and ICAD are not in the SET com-
BER. Disruption of DNA repair might explain why loss plex. Therefore the SET complex is probably not in-
of ndk in E. coli leads to a mutator phenotype and why volved during caspase activation. However, serine
NM23-H1 is heavily implicated in cancer prognosis. Loss protease inhibitors block caspase-mediated apoptosis
of NM23-H1 expression in tumors might also make them (Weaver et al., 1993). An unknown endogenous serine
resistant to immune surveillance by CTL and NK cells, protease may, therefore, activate a DNA nicking enzyme
since target cells with silenced NM23-H1 are less sensi- as a first step in caspase DNA degradation. However,
tive to GzmA-induced cell death. In the SET complex during CTL and NK cell killing, NM23-H1 may nick DNA
HMG-2, which preferentially recognizes distorted DNA into large fragments before CAD-triggered oligonucleo-
structures including single-stranded DNA, may help tar- somal DNA fragmentation. This might contribute to the
get NM23-H1 and Ape1 to damaged DNA in need of synergy of GzmA and GzmB in degrading chromatin
repair and to paranemic regions of DNA implicated in (Beresford et al., 1999; Nakajima et al., 1995).
transcriptional regulation. The NAP activity of SET might
Experimental Proceduresalso play a role in making nucleosomal DNA accessible
to repair and/or transcriptional activation. There have
Cell Lines and Antibodiesbeen no studies of the influence of chromatin structure
K562, Jurkat, and HeLa cells (ATCC) were grown in RPMI1640 withon BER. However, damaged DNA in activating tran-
10% FCS, 2 mM glutamine, 2 mM HEPES, 100 units/ml penicillin,
scribed genes (with more open chromatin) is preferen- 100 mg/ml streptomycin, and 50 M -mercaptoethanol. Mouse
tially repaired (Bohr et al., 1985). In fact, a DNA oligonu- pp32 mAb (RJ1) and SET rabbit antiserum were described (Beres-
cleotide containing a T(6-4)T photoproduct was repaired ford et al., 2001). Mouse SET and TAF-I mAbs were kind gifts of
K. Nagata (Nagata et al., 1998). Commercial antibodies were rabbitten times less efficiently in nucleosomal DNA than in
antisera against CAD (Molecular Biologische Technologie); ICAD,naked DNA (Hara et al., 2000). Apparently, under normal
HMG-2 (BD PharMingen); Ape1, NM23-H1, NM23-H2 (Santa Cruz);circumstances, the nicks initiated by NM23-H1 are
calreticulin (Stressgen Biotech Corp.); and GST (Clontech); mouse
quickly repaired (perhaps using Ape1). However, during mAb against NM23-H1 (BD PharMingen) and -actin (Sigma-
GzmA-mediated cell death, Ape1 is a GzmA substrate, Aldrich); and HRP-conjugated sheep anti-mouse IgG, HRP-conju-
and its cleavage leads to loss of function. Therefore, gated monkey anti-rabbit IgG (Amersham), FITC-conjugated goat
anti-rabbit IgG (Zymed), and TRITC-conjugated goat anti-mouse IgGGzmA hijacks a DNA repair pathway and converts it to
(Molecular Probes). Coprecipitation and immunoblot were per-induce DNA damage.
formed as described (Fan et al., 2003).The SET complex proteins are implicated not only in
DNA repair, but also in transcription. SET binds CBP/
Recombinant Proteins, Expression Plasmids,
p300 and inhibits histone acetylation and DNA demeth- and Purified Perforin
ylation (Cervoni et al., 2002; Seo et al., 2001, 2002; Shi- GzmA and GzmB and inactive S-A mutants were expressed and
purified as previously reported (Beresford et al., 1999). Perforin waskama et al., 2000). Ape1 reduces oxidized transcription
Cell
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purified from rat RNK-16 cells, and cells were loaded with Gzms Pharmaceuticals) for 1 hr at 37C. After washing with PBS, 100 l
culture medium containing 1 mM EGTA was added to each chamber.using a sublytic concentration of perforin as described (Shi et al.,
1992). pp32, SET, and GST were expressed in BL21-DE3 cells and LAK cells (generated from human PBMCs cultured for 14 days in
medium containing 1000 IU/ml recombinant human IL-2 (a gift ofpurified as described (Zhang et al., 2001b). Recombinant NM23-H1
was purified by ammonium sulfate precipitation followed by hy- Chiron Oncology) added in 100 l of medium containing 1 mM EGTA
onto ConA-sensitized target cells (at a ratio of 40:1 for microscopydroxyapatite, ATP agarose, and DEAE ion exchange (Pharmacia)
fractionation using NM23-H1 expressed from pet 15b, a kind gift of and 1:1 for immunoblot) were incubated for 15 min at 37C, briefly
centrifuged onto the targets, and incubated for another 15 min atP. Steeg (National Institutes of Health, USA). Mammalian expression
plasmids for NM23-H1 and NM23-H2 cDNA in pCMV were kind gifts 37C. Adding CaCl2 to a final concentration of 5 mM triggered granule
exocytosis. Slides were returned to 37C, and reactions wereof P. Steeg and E. Postel (Princeton University), respectively. SET
was cloned into pcDNA3.1 for transfection experiments. stopped at indicated times by adding fixation buffer. Samples were
either lysed in NP40 lysis buffer to obtain nuclear and cytoplasmic
fractions or were stained and analyzed by microscopy as above.Purification of SET Complex and DNase
The SET complex was eluted from a S-AGzmA column loaded with
In Vitro Cleavage AssayK562 cell lysates as described (Fan et al., 2003). The concentrated
Recombinant proteins (0.5 M) or K562 cell lysates (2  105 celldesalted eluate was applied in Tris-buffered saline to a Sephacryl
equivalents) were incubated for the indicated times at 37C with400 gel filtration (2.5 cm  1.0 m; Pharmacia). The pooled S400
indicated concentrations of Gzms in 20 l of 50 mM Tris-HCl (pHfractions were concentrated, desalted, and separated on a 2 ml
7.5), 1 mM CaCl2, and 1 mM MgCl2. Reaction products were electro-anion exchange Q column (Pharmacia) eluted with 0–1 M NaCl.
phoresed and transferred to nitrocellulose for immunoblot.
DNA Nicking Assay
Silencing by RNAiThe Klenow fragment of DNA polymerase (New England Biolabs)
Silencing using synthetic 21 nucleotide siRNA duplexes was per-labeled DNA breaks as described (Beresford et al., 1999). NP40 cell
formed as described (Fan et al., 2003). Synthetic siRNAs (Dhar-lysates were treated with Gzms at 37C for 4 hr and then nuclei
macon Research) were as follows: NM23-H1 siRNA#1: sense 5-isolated by centrifugation were washed before labeling. For some
GGAUUCCGCCUUGUGGGUCUU-3, antisense 5-GACCCACAAGGexperiments, isolated untreated nuclei were incubated directly with
CGGAAUCCUU-3; #2 sense 5-UACAUGCACUCAGGGCCGGUU-3,indicated combinations of 5 g of purified SET complex and recom-
antisense 5-CCGGCCCUGAGUGCAUGUAUU-3; NM23H2: #1binant proteins for 4 hr at 37C. Unless otherwise indicated, concen-
sense 5-GGGAUUCCGCCUCGUGGCCUU-3, antisense 5-GGCCAtrations were 0.2 M for rSET, rNM23-H1, or rGST, and 1 M for
CGAGGCGGAAUCCCUU-3; #2 sense 5-GUACAUGAACUCAGGGGzms. For immunodepletion, the SET complex was treated with 5
CCGUU-3, antisense 5-CGGCCCUGAGUUCAUGUACUU-3; SET:g indicated antibodies and Protein A Sepharose before adding
#1 sense 5-GGAGCUCAACUCCAACCACUU-3; antisense 5-GUGGzms. For rescue, 50 nM rGST, rSET, and/or rNM23H1 was added
GUUGGAGUUGAGCUCCUU-3; #2 sense 5-GGCCGACGAGACCUto the immunodepleted supernatants. Washed nuclei were labeled
CAGAAUU-3, antisense 5-UUCUGAGGUCUCGUCGGCCUU-3.with Klenow and 32P-dATP and analyzed by scintillation counting or
GFP siRNA sequences were previously described (Fan et al., 2003).alkaline gel electrophoresis as described (Beresford et al., 1999).
K562 cells were analyzed 3 days after transfection by immunoblot
for protein expression and by cytotoxicity assay after loading withIn Situ Nicking Assay
granzyme and perforin. Transfected cell lysates were also treatedIsolated K562 nuclei were treated for 90 min at 37C with combina-
with Gzms to analyze DNA nicking as described above.tions of 0.5 M GzmA or S-AGzmA, 10 U DNase I (New England
Biolabs), and K562 cytosol (2  104 cell equivalents) in 100 l 50
Overexpression of NM23-H1, NM23-H2, and SETmM Tris-HCl (pH 7.9); 50 g/ml BSA; 5 mM MgCl2; 10 mM
K562 cells, transfected with pCMV or pcDNA3.1 expression plas--mercaptoethanol; 4 U Klenow; 100 M dATP, dCTP, and dGTP;
mids 3 days earlier as described (Fan et al., 2003), were analyzedand 16 M Alexa 568-12-UTP (Molecular Probes), adapting the
by immunoblot and DNA nicking assay as described for silencedmethod of Krystosek, 1999. Nuclei were then plated onto polyLys-
cells.coated slides and fixed and permeabilized using the Fix-and-Perm
kit (Caltag Laboratories). After washing with PBS, slides were coun-
Acknowledgmentsterstained with 0.05 g/ml SYTOX Green (Molecular Probes),
washed again, and mounted with ProLong Antifade medium (Molec-
This work was supported by NIH Grant AI45587 (J.L.). We thank Z.ular Probes). Images were acquired with a Bio-Rad Radiance 2000
Xu for technical support, L. Shi for helpful discussions, P. Steeglaser-scanning confocal microscope.
for NM23-H1 plasmids, E. Postel for NM23-H2 plasmid and critical
review of the manuscript, K. Nagata for SET and TAF-I antibodies,Plasmid DNA Digestion and Nucleosome Assembly Assay
and C. Novina for GFP siRNA.Plasmid pcDNA3.1 (0.5 g) was incubated in 20 l of Tris-HCl (pH
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